AAAAAA
Results:
1-8
|
Results: 8
Authors:
Billon, S
Blouch, MT
Escoffre-Barbe, M
Le Niger, C
Le Roux, AM
Abgrall, JF
Citation: S. Billon et al., A case of chronic myelomonocytic leukaemia and factor XI deficiency with acirculating anticoagulant, HAEMOPHILIA, 7(4), 2001, pp. 433-436
Authors:
Billon, S
Le Niger, C
Escoffre-Barbe, M
Vicariot, M
Abgrall, JF
Citation: S. Billon et al., The use of recombinant factor VIIa (NovoSeven (R)) in a patient with a factor XI deficiency and a circulating anticoagulant, BL COAG FIB, 12(7), 2001, pp. 551-553
Authors:
Billon, S
Mercier, B
Feree, C
Abgrall, JF
Citation: S. Billon et al., Genetic analysis after allograft: prudence!, PRESSE MED, 29(24), 2000, pp. 1353-1353
Authors:
Harousseau, JL
Witz, B
Lioure, B
Hunault-Berger, M
Desablens, B
Delain, M
Guilhot, F
Le Prise, PY
Abgrall, JF
Deconinck, E
Guyotat, D
Vilque, JP
Casassus, P
Tournilhac, O
Audhuy, B
Solary, E
Citation: Jl. Harousseau et al., Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques, J CL ONCOL, 18(4), 2000, pp. 780-787
Authors:
Colombat, P
Cornillet, P
Deconinck, E
Tourani, JM
Gardembas, M
Delain, M
Abgrall, JF
Kootz, C
Milpied, N
Citation: P. Colombat et al., Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMSphase II study, BONE MAR TR, 26(9), 2000, pp. 971-977
Authors:
Billon, S
Escoffre-Barbe, M
Mercier, B
Abgrall, JF
Ferec, C
Citation: S. Billon et al., Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients, THROMB HAEM, 81(4), 1999, pp. 659-660
Authors:
Leroyer, C
Bressollette, L
Oger, E
Mansourati, J
Cheze-Le Rest, C
Nonent, M
Buchmuller, A
Tardy, B
Decousus, H
Parent, F
Simonneau, G
Juste, K
Ill, P
Abgrall, JF
Clavier, J
Mottier, D
Citation: C. Leroyer et al., Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis - A randomized clinical trial, HAEMOSTASIS, 28(2), 1998, pp. 70-77
Authors:
Hilbert, L
Gaucher, C
Abgrall, JF
Parquet, A
Trzeciak, C
Mazurier, C
Citation: L. Hilbert et al., Identification of new type 2B von Willebrand disease mutations: Arg543Gln,Arg545Pro and Arg578Leu, BR J HAEM, 103(3), 1998, pp. 877-884
Risultati:
1-8
|